Coston McIsaac & Partners’s Viatris VTRS Stock Holding History
Bought
Maintained
Sold
Other funds holding VTRS
DSA
RCMNY
Coston McIsaac & Partners's VTRS Position: Q2 2026 in Review
Coston McIsaac & Partners increased its Viatris (VTRS) stake by 0.23% in Q2 2026, buying an estimated $31 and bringing the position to 885 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #546.
Coston McIsaac & Partners first reported a position in VTRS in Q2 2022 and has held it in 17 quarters since. The position peaked at $23K in Q1 2024. 1,026 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.
- Coston McIsaac & Partners held 885 shares of Viatris worth $14K as of Q2 2026.
- Coston McIsaac & Partners bought 2 Viatris shares in Q2 2026, an estimated $31.
- Viatris made up ﹤0.01% of Coston McIsaac & Partners's portfolio in Q2 2026, its #546 holding.
- Coston McIsaac & Partners first reported a position in Viatris in Q2 2022 and has held it in 17 quarters since.
- Coston McIsaac & Partners's Viatris position peaked at $23K in Q1 2024.
- 1,026 funds tracked by Wall St. Rank held Viatris as of Q2 2026.
Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.